Buscar
Anika Therapeutics Inc
ANIKAñadir a la lista de seguimiento
14.770USD
-0.370-2.44%
Cierre 05/08, 16:00（ET）Cotizaciones retrasadas 15 min
205.14MCap. mercado
PérdidaP/E TTM
Más Datos de Anika Therapeutics Inc Compañía
Anika Therapeutics, Inc. is engaged in the osteoarthritis pain management and regenerative solutions space focused on early intervention orthopedics. The Company is leveraging its core expertise in hyaluronic acid and implant solutions. It partners with clinicians to provide minimally invasive products that restore active living for people around the world. It is developing, manufacturing and commercializing products on its hyaluronic acid (HA) technology platform. It is focused on spaces within orthopedics, including osteoarthritis pain management and regenerative solutions, and its products are delivered in key sites of care, including ambulatory surgery centers. Its products include OA Pain Management, Regenerative Solutions, and others. The OA Pain Management product family consists of Cingal, Monovisc, Orthovisc, Orthovisc mini and Orthovisc-T. Its Regenerative Solutions include Integrity, Hyalofast, Tactoset and NanoFx.
Información de Anika Therapeutics Inc
Símbolo de cotizaciónANIK
Nombre de la empresaAnika Therapeutics Inc
Fecha de salida a bolsaMay 16, 1985
Director ejecutivoBlanchard (Cheryl Renee)
Número de empleados288
Tipo de seguridadOrdinary Share
Fin del año fiscalMay 16
Dirección32 Wiggins Ave
CiudadBEDFORD
Bolsa de valoresNASDAQ OMX - NASDAQ BASIC
PaísUnited States of America
Código postal01730-2315
Teléfono17814579000
Sitio Webhttps://anika.com/
Símbolo de cotizaciónANIK
Fecha de salida a bolsaMay 16, 1985
Director ejecutivoBlanchard (Cheryl Renee)
Ejecutivos de Anika Therapeutics Inc
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+28.18%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+35.55%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+61.31%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
22.36K
+59.44%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+69.42%
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Ms. Susan L. N. Vogt
Ms. Susan L. N. Vogt
Independent Director
Independent Director
--
--
Mr. David B. Colleran, J.D.
Mr. David B. Colleran, J.D.
Executive Vice President, General Counsel, Secretary
Executive Vice President, General Counsel, Secretary
--
--
Mr. John Bell (Jack) Henneman, III
Mr. John Bell (Jack) Henneman, III
Independent Chairman of the Board
Independent Chairman of the Board
--
--
Mr. Stephen O. Richard
Mr. Stephen O. Richard
Independent Director
Independent Director
--
--
Ver más
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Dr. Glenn R. Larsen, Ph.D.
Dr. Glenn R. Larsen, Ph.D.
Independent Director
Independent Director
50.26K
+28.18%
Ms. Sheryl L. Conley
Ms. Sheryl L. Conley
Independent Director
Independent Director
39.84K
+35.55%
Mr. William R. (Bill) Jellison
Mr. William R. (Bill) Jellison
Independent Director
Independent Director
23.10K
+61.31%
Mr. Stephen D. (Steve) Griffin
Mr. Stephen D. (Steve) Griffin
Chief Financial Officer, Chief Operating Officer, Executive Vice President
Chief Financial Officer, Chief Operating Officer, Executive Vice President
22.36K
+59.44%
Mr. Joseph H. (Joe) Capper
Mr. Joseph H. (Joe) Capper
Independent Director
Independent Director
20.40K
+69.42%
Dr. Cheryl Renee Blanchard, Ph.D.
Dr. Cheryl Renee Blanchard, Ph.D.
President, Chief Executive Officer, Director
President, Chief Executive Officer, Director
--
--
Desglose de ingresos
Divisa: USDActualizado: lun., 6 de abr
Divisa: USDActualizado: lun., 6 de abr
FY2025
FY2025Q4
FY2025Q3
FY2025Q2
FY2025Q1
FY2024
FY2024Q4
FY2024Q3
FY2024Q2
FY2024Q1
FY2023
FY2023Q4
FY2023Q3
FY2023Q2
FY2023Q1
FY2022
FY2022Q4
FY2022Q3
FY2022Q2
FY2022Q1
FY2021
FY2020
FY2019
FY2018
Por negocioUSD
Nombre
Ganancia
Proporción
OEM Channel
64.41M
57.09%
Commercial Channel
48.41M
42.91%
Por regiónUSD
Nombre
Ganancia
Proporción
United States
70.06M
62.10%
Europe
22.21M
19.69%
Other
20.55M
18.21%
Por negocio
Por región
Por negocioUSD
Nombre
Ganancia
Proporción
OEM Channel
64.41M
57.09%
Commercial Channel
48.41M
42.91%
Estadísticas de accionistas
Actualizado: vie., 8 de may
Actualizado: vie., 8 de may
Accionistas
Tipos de accionistas
Accionistas
Accionistas
Proporción
Caligan Partners, LP
10.79%
BlackRock Institutional Trust Company, N.A.
6.87%
The Vanguard Group, Inc.
5.82%
BlackRock Financial Management, Inc.
5.23%
Acadian Asset Management LLC
4.56%
Otro
66.73%
Accionistas
Accionistas
Proporción
Caligan Partners, LP
10.79%
BlackRock Institutional Trust Company, N.A.
6.87%
The Vanguard Group, Inc.
5.82%
BlackRock Financial Management, Inc.
5.23%
Acadian Asset Management LLC
4.56%
Otro
66.73%
Tipos de accionistas
Accionistas
Proporción
Investment Advisor
33.05%
Investment Advisor/Hedge Fund
29.77%
Hedge Fund
26.08%
Research Firm
7.36%
Individual Investor
5.93%
Pension Fund
0.80%
Venture Capital
0.17%
Bank and Trust
0.16%
Family Office
0.08%
Participación institucional
Actualizado: mié., 1 de abr
Actualizado: mié., 1 de abr
Periodo del informe
Número de instituciones
Acciones mantenidas
Proporción
Cambio
2026Q1
264
12.85M
96.55%
-1.61M
2025Q4
245
12.37M
97.19%
-666.00
2025Q3
267
12.37M
100.32%
-461.27K
2025Q2
295
12.88M
103.23%
-71.30K
2025Q1
297
12.95M
103.38%
-1.70M
2024Q4
298
12.83M
102.20%
-560.99K
2024Q3
297
13.48M
104.72%
-150.44K
2024Q2
301
13.64M
105.78%
+30.78K
2024Q1
301
13.61M
105.08%
-1.78M
2023Q4
304
13.45M
105.34%
+303.47K
Ver más
Actividad de los accionistas
Nombre
Acciones mantenidas
Proporción
Cambio
Cambio %
Fecha
Caligan Partners, LP
1.44M
10.71%
--
--
Jan 23, 2026
BlackRock Institutional Trust Company, N.A.
914.28K
6.82%
-6.31K
-0.69%
Dec 31, 2025
The Vanguard Group, Inc.
779.16K
5.81%
-1.50K
-0.19%
Dec 31, 2025
BlackRock Financial Management, Inc.
695.72K
5.19%
-80.71K
-10.40%
Dec 31, 2025
Acadian Asset Management LLC
606.54K
4.53%
-26.25K
-4.15%
Dec 31, 2025
Boothbay Fund Management, LLC
534.51K
3.99%
-5.13K
-0.95%
Dec 31, 2025
Morgan Stanley & Co. LLC
519.94K
3.88%
+372.34K
+252.25%
Dec 31, 2025
Renaissance Technologies LLC
515.72K
3.85%
-17.30K
-3.25%
Dec 31, 2025
Dimensional Fund Advisors, L.P.
494.32K
3.69%
-106.84K
-17.77%
Dec 31, 2025
The Capital Management Corporation
500.46K
3.73%
-50.78K
-9.21%
Dec 31, 2025
Ver más
ETFs relacionados
Actualizado: sáb., 6 de dic
Actualizado: sáb., 6 de dic
Nombre
Proporción
Invesco NASDAQ Future Gen 200 ETF
0.56%
Royce Quant Small-Cap Quality Value ETF
0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
0.1%
iShares Micro-Cap ETF
0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
0.01%
Avantis US Small Cap Equity ETF
0.01%
Invesco RAFI US 1500 Small-Mid ETF
0.01%
WisdomTree US SmallCap Fund
0.01%
iShares Russell 2000 Value ETF
0.01%
Ver más
Invesco NASDAQ Future Gen 200 ETF
Proporción0.56%
Royce Quant Small-Cap Quality Value ETF
Proporción0.2%
SPDR SSGA US Small Cap Low Volatility Index ETF
Proporción0.1%
iShares Micro-Cap ETF
Proporción0.02%
Goldman Sachs ActiveBeta US Small Cap Equity ETF
Proporción0.02%
JPMorgan Diversified Return U.S. Small Cap Equity ETF
Proporción0.01%
Avantis US Small Cap Equity ETF
Proporción0.01%
Invesco RAFI US 1500 Small-Mid ETF
Proporción0.01%
WisdomTree US SmallCap Fund
Proporción0.01%
iShares Russell 2000 Value ETF
Proporción0.01%
Dividendos
Un total de
0.00
USD se ha distribuido en dividendos durante los últimos 5 años.
Fecha
Dividendos
Fecha de registro
Fecha de pago
Fecha ex-dividendo
Sin datos
División de acciones
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
Fecha
Fecha ex-dividendo
Tipo
Relación
Sin datos
